32
views
0
recommends
+1 Recommend
0 collections
    3
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Inhibition of Parathyroid Hormone Secretion by Caffeine in Human Parathyroid Cells

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Context and Objective:

          Caffeine is a highly consumed psychoactive substance present in our daily drinks. Independent studies have reported associations between caffeine consumption, low bone mineral density, and urinary calcium loss, as well as impaired bone development in vitro and in vivo. Calcium (Ca 2+), vitamin D, and PTH are critical regulators of bone remodeling. A possible association between caffeine and parathyroid gland function has been suggested in the literature.

          Design, Setting, and Patients:

          Effects of caffeine on PTH secretion and Ca 2+ levels were determined by batch incubation and Fura-2, respectively, in pathological parathyroid cells. Protein expressions were studied by Western blot and immunohistochemistry in normal and parathyroid adenoma tissues. Alterations in gene expressions of adenosine receptor A1 ( ADORA1) and A2 ( ADORA2A) and PTH were quantified by PCR; intracellular cAMP levels and protein kinase A activity were analyzed by an antibody-based assay.

          Results:

          We studied physiological concentrations of caffeine ranging from 1 to 50 μ m and found that 50 μ m caffeine caused a significant decrease of PTH secretion and PTH gene expression. This decrease occurred in parallel with a decrease of the intracellular cAMP level, protein kinase A activity, and ADORA1 gene expression, indicating a possible causal relationship. The intracellular level of Ca 2+ was unaffected even by high concentrations of caffeine. Protein expressions demonstrated two main targets for caffeine—ADORA 1 and ADORA 2A.

          Conclusion:

          A physiological high dose of caffeine inhibits PTH secretion in human parathyroid cells, possibly due to a decrease of the intracellular level of cAMP. The observation demonstrates a functional link between caffeine and parathyroid cell function.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: found
          • Article: not found

          Molecular and cellular mechanisms of the anabolic effect of intermittent PTH.

          Intermittent administration of parathyroid hormone (PTH) stimulates bone formation by increasing osteoblast number, but the molecular and cellular mechanisms underlying this effect are not completely understood. In vitro and in vivo studies have shown that PTH directly activates survival signaling in osteoblasts; and that delay of osteoblast apoptosis is a major contributor to the increased osteoblast number, at least in mice. This effect requires Runx2-dependent expression of anti-apoptotic genes like Bcl-2. PTH also causes exit of replicating progenitors from the cell cycle by decreasing expression of cyclin D and increasing expression of several cyclin-dependent kinase inhibitors. Exit from the cell cycle may set the stage for pro-differentiating and pro-survival effects of locally produced growth factors and cytokines, the level and/or activity of which are known to be influenced by PTH. Observations from genetically modified mice suggest that the anabolic effect of intermittent PTH requires insulin-like growth factor-I (IGF-I), fibroblast growth factor-2 (FGF-2), and perhaps Wnts. Attenuation of the negative effects of PPAR gamma may also lead to increased osteoblast number. Daily injections of PTH may add to the pro-differentiating and pro-survival effects of locally produced PTH related protein (PTHrP). As a result, osteoblast number increases beyond that needed to replace the bone removed by osteoclasts during bone remodeling. The pleiotropic effects of intermittent PTH, each of which alone may increase osteoblast number, may explain why this therapy reverses bone loss in most osteoporotic individuals regardless of the underlying pathophysiology.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Nomenclature and classification of purinoceptors.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women.

              Consumption of coffee and tea, and total intake of caffeine has been claimed to be associated with osteoporotic fracture risk. However, results of earlier studies lack consistency. We examined this relation in a cohort of 31,527 Swedish women aged 40-76 years at baseline in 1988. The consumption of coffee, caffeinated tea and the intake of caffeine were estimated from a self-administered food frequency questionnaire (FFQ). Multivariate-adjusted hazards ratios (HRs) of fractures with 95% confidence intervals (95% CIs) were estimated by Cox proportional hazards models. During a mean follow-up of 10.3 years, we observed 3,279 cases with osteoporotic fractures. The highest (>330 mg/day) compared with the lowest ( or =4 cups (600 ml)/day of coffee compared to or =2 fracture types) revealed a HR of 1.88 (95% CI: 1.17-3.00). In conclusion, our results indicate that a daily intake of 330 mg of caffeine, equivalent to 4 cups (600 ml) of coffee, or more may be associated with a modestly increased risk of osteoporotic fractures, especially in women with a low intake of calcium.
                Bookmark

                Author and article information

                Journal
                J Clin Endocrinol Metab
                J. Clin. Endocrinol. Metab
                jcem
                jceme
                jcem
                The Journal of Clinical Endocrinology and Metabolism
                Endocrine Society (Chevy Chase, MD )
                0021-972X
                1945-7197
                August 2013
                20 June 2013
                20 June 2013
                : 98
                : 8
                : E1345-E1351
                Affiliations
                Departments of Molecular Medicine and Surgery (L.-O.F., R.B.), and Oncology-Pathology (M.L., C.L.), Karolinska Institutet, SE-171 76 Stockholm, Sweden; and Department of Geriatric Endocrinology (M.L.), First Affiliated Hospital of Guangxi Medical University, Nanning 520021, China
                Author notes
                Address all correspondence and requests for reprints to: Dr Ming Lu, Karolinska University Hospital CCK, R8:04, SE-171 76 Stockholm, Sweden. E-mail: ming.lu@ 123456ki.se .
                Article
                13-1466
                10.1210/jc.2013-1466
                4207951
                23788688
                9e460c46-4846-4d12-b051-ff430c9fd1a3
                Copyright © 2013 by The Endocrine Society

                This article has been published under the terms of the Creative Commons Attribution License ( CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Copyright for this article is retained by the author(s). Author(s) grant(s) the Endocrine Society the exclusive right to publish the article and identify itself as the original publisher.

                History
                : 22 February 2013
                : 13 June 2013
                Categories
                2
                5
                Hot Topics in Translational Endocrinology
                Endocrine Research

                Endocrinology & Diabetes
                Endocrinology & Diabetes

                Comments

                Comment on this article